Cancer Progression May Be Delayed With New Melanoma Treatment
Researchers have discovered that a two-drug combination can delay treatment residence in patients with advanced melanoma. The kinase inhibitor drugs dabrafenib and tramentinib combined target different points in the same growth-factor pathway. This postponed the development of drug resistance in patients with BRAF-positive metastatic melanoma, the authors of the study claim. Melanoma is the most […]
min read